Navigation Links
PRA Expert to Present at Pharmacovigilance Conference
Date:11/22/2011

RALEIGH, N.C., Nov. 22, 2011 /PRNewswire/ -- PRA, a leading Clinical Research Organization, announces that the head of our Safety and Risk Management (SRM) group will speak at VIBPharma's 7th Annual Pharmacovigilance, Drug Safety and Risk Management conference being held in Brussels, Belgium from 22-23 November 2011.  PRA will also host an exhibit at booth #1, where additional SRM representatives will be available to discuss PRA's approach to pharmacovigilance.

On 22 November at 11:10AM CET, Dr. Sabine Richter, PRA's Vice President of SRM, will deliver a presentation titled, "Rationalising How Outsourcing Pharmacovigilance Activities Can Strengthen Your Regulatory Compliance and Immensely Increase Flexibility." Dr. Richter will discuss the key benefits of outsourcing drug safety services, review best practices for vendor management, and explore risk-sharing techniques that create effective cost reductions.

Dr. Richter has over 25 years of research experience in the pharmaceutical and clinical research industries as well as in academia. Since joining PRA's SRM team in 2004, she has delivered numerous projects for a variety of clients and led large, long-term safety programs involving as many as 50 countries on five continents. As the head of PRA's SRM group, Dr. Richter has developed robust procedures and quality control measures to ensure consistent high performance and regulatory compliance.

PRA's SRM group provides services throughout the entire product life cycle. The team includes over 100 experts available to clients for consultancy as well as routine and specialty pharmacovigilance services. Most of these staff members are healthcare professionals (nurses, pharmacists, physicians) or life scientists.  PRA's drug safety centers are based in our Mannheim, Germany; Swansea, UK; Charlottesville, VA (US); and Sao Paulo, Brazil offices.

About PRA

PRA is transforming clinical trials through our people, innovation and transparency.  PRA provides personalized service customized to the unique requirements of each study. We support our global reach and innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals.

We serve our clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge.  Offering services in 80+ countries and serving sponsors for 30+ years, we have amassed a level of expertise that has enabled us to work on a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs.  But at PRA, we are looking to the future, not the past.  Our increasingly forward-thinking approach to transforming the clinical trial landscape will continue to make a difference to healthcare patients around the world.

To learn more about PRA, please visit praintl.com, email endpoints@praintl.com or call our Global Headquarters.


'/>"/>
SOURCE PRA
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
2. The Foremost Expert on Morgellons Disease Highlights the Gravity of This Illness
3. Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy
4. Mind-Controlled Bionic Limbs Holding Promise, and the Demand is Growing say IEEE Experts
5. Kendle Experts to Address Key Industry Issues at Drug Information Association 47th Annual Meeting
6. High voltage! Power experts pull out all the stops at international energy meeting
7. Expert Offers Solution to Hair Loss Concerns
8. Tengion Announces Addition of Two Renal Experts to Research & Development Advisors Panel
9. Best Practices, LLC Showcases Its Expertise in Customer Relationship Management
10. M-3 Information, a Leader in Expert Behavioral Health Solutions, Launches M3Clinician.com
11. Reagent Agent(SM) Transfection Cell Line Database From The Transfection Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... ... 15, 2017 , ... Nanomedical Diagnostics , a cutting-edge ... the launch of the new NHS Agile biosensor chip . The new ... a wide range of molecules, including small and large molecules, peptides, proteins, and ...
(Date:8/15/2017)... ... August 15, 2017 , ... Coffea arabica ... biotic and abiotic factors. During this educational webinar, participants will learn about the ... as gain a better understanding of how genomics is important for coffee breeding ...
(Date:8/11/2017)... ROCKVILLE, Md. , Aug. 11, 2017 ... in a New York Times article regarding ... 9.2 billion, according to Kalorama Information.  The ... an App for That"  used information ... Remote Patient Monitoring & Telemedicine Market  (Sleep, ...
(Date:8/10/2017)... Philadelphia, PA (PRWEB) , ... August 09, 2017 ... ... back to the classroom next week-- as students. From August 14th through the ... Institute. The institute, which debuted in the summer of 2016, provides Philadelphia-based middle ...
Breaking Biology Technology:
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Access System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 15.1% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):